← Back to Search

Behavioural Intervention

eXciteOSA for Obstructive Sleep Apnea (AEGIS Trial)

N/A
Waitlist Available
Led By Alexandre Abreu, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

AEGIS Trial Summary

This trial will assess how well people with mild obstructive sleep apnea adhere to the eXciteOSA device, and whether higher electrical stimulation leads to better adherence. The study will also measure the device's effectiveness in improving sleep apnea and quality of life.

Eligible Conditions
  • Obstructive Sleep Apnea

AEGIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean Number of Days Device Was Used
Secondary outcome measures
Epworth Sleepiness Scale (ESS) Scores
Mean Respiratory Event Index (REI)
Number of Participants Accepting Long Term Treatment
+5 more

AEGIS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Low intensity application of eXciteOSAExperimental Treatment1 Intervention
Participants will receive the eXciteOSA device intervention at low intensity application for 20 minutes per day for 6 consecutive weeks.
Group II: High intensity application of eXciteOSAActive Control1 Intervention
Participants will receive the eXciteOSA device intervention at high intensity application for 20 minutes per day for 6 consecutive weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eXciteOSA
2022
N/A
~110

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
911 Previous Clinical Trials
411,153 Total Patients Enrolled
Alexandre Abreu, MDPrincipal InvestigatorUniversity of Miami
Naresh Punjabi, MDPrincipal InvestigatorUniversity of Miami
3 Previous Clinical Trials
335 Total Patients Enrolled
~11 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top